Peripheral vascular occlusions leading to gangrene and amputations in antiphospholipid antibody positive patients

Annals of the New York Academy of Sciences

Volumn 1108, Issue , 2007, Pages 515-529

  Asherson, Ronald A ^a   Cervera, Ricard ^b   Shoenfeld, Yehuda ^c  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b HOSPITAL CLÍNIC   (Spain)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Amputations; Antiphospholipid antibodies; Catastrophic antiphospholipid (Asherson's) syndrome; Livedo reticularis; Peripheral vascular diseases; Primary antiphosholipid syndrome; Systemic lupus erythematosus; Vasculitis

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; PHOSPHOLIPID ANTIBODY; STEROID;

AMPUTATION; ANTIPHOSPHOLIPID SYNDROME; AORTA BIFURCATION; AORTA OCCLUSION; ASHERSON SYNDROME; ATHEROSCLEROSIS; BLOOD VESSEL OCCLUSION; CONFERENCE PAPER; CONNECTIVE TISSUE DISEASE; DISCOID LUPUS ERYTHEMATOSUS; DISSEMINATED INTRAVASCULAR CLOTTING; GANGRENE; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LIVEDO RETICULARIS; NECROSIS; PERIPHERAL VASCULAR DISEASE; PLASMAPHERESIS; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULAR DISEASE; VASCULITIS;

DISCOIDAE;

EID: 34948874137     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1422.055     Document Type: Conference Paper

References (50)

1. HARRIS, E.N., A.E. GHARAVI, S.P. PATEL & G.R.V. HUGHES. 1987. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held April 4 1986. Clin. Exp. Immunol. 68: 215-222.
2. AMITAL, H., Y. LEVY, C. DAVIDSON, et al. 2001. Catastrophic antiphospholipid syndrome-remission following leg amputation in two cases. Sem. Arthritis. Rheum. 31: 127-132.
3. HARRIS, E.N., E. BAGULEY, R.A. ASHERSON & G.R.V. HUGHES. 1987. Clinical and serological features of the antiphospholipid syndrome (APS) (Abstract). Br. J. Rheumatol. 26(Suppl 2): 19.
4. KHAMASHTA, M.A. & R.A. ASHERSON. 1995. Hughes' Syndrome: antiphospholipid antibodies move closer to thrombosis in 1994. Br. J. Rheumatol. 34: 493-494.
5. HUGHES, G.R.V. 1983. Thrombosis, abortion, cerebral disease and the "lupus anticoagulant." Br. Med. J. 287: 47-51.
6. MIYAKIS, S., M.D. LOCKSHIN, T. ATSUMI, et al. 2006. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome. J. Thromb. Hemost. 4: 295-306.
7. ASHERSON, R.A. 1992. The catastrophic antiphospholipid syndrome. J. Rheumatol. 19: 508-512.
8. PIETTE, J.-C., R. CERVERA, R. LEVY, et al. 2003. The catastrophic antiphospholipid syndrome - Asherson's syndrome. Ann. Med. Interne. 154: 195-196.
9. ALARCON-SEGOVIA, D. & P.J. OSMUNDSON. 1965. Peripheral vascular syndromes associated with systemic lupus erythematosus. Ann. Intern. Med. 62: 907-919.
10. JINDAL, S.K., M.F.R. MARTIN & A. GAYNER. 1983. Gangrene developing after minor surgery with undiagnosed systemic lupus erythematosus. Ann. Rheum. Dis. 42: 347-349.
11. HALL, S., H. BUETTNER & H.S. LUTHRA. 1984. Occlusive vascular disease in systemic lupus erythematosus. J. Rheumatol. 11: 846-850.
12. ASHERSON, R.A., R.H.W.M. DERKSEN, E.N. HARRIS, et al. 1986. Large vessel occlusion and gangrene in systemic lupus erythematosus and "lupus-like" disease. A report of six cases. J. Rheumatol. 13: 740-747.
13. DU BOIS, E.L. & J.D. ARTERBERRY. 1962. Gangrene as a manifestation of systemic lupus erythematosus. JAMA 181: 366-374.
14. YANG, S.G., K.H. KIM, K.C. PARK, et al. 1996. A case of systemic lupus erythematosus showing acute gangrenous changes of fingertips. Br. J. Dermatol. 134: 178-192.
15. CAMPOS, L.M., M.H. KISS, E.A. D'AMICO & C.A. SILVA. 2003. Antiphospholipid antibodies and the antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus. Lupus 12: 820-826.
16. NOJIMA, J., E. SUEHISA, N. AKITA, et al. 1997. Risk of arterial thrombosis in patients with anticardiolipin antibodies and lupus anticoagulant. Br. J. Haematol 96: 447-450.
17. SEAMAN, D.E., A.V. LONDINO, JR., C.K. KWOH, et al. 1995. Antiphospholipid antibodies in pediatric systemic lupus erythematosus. Pediatrics 96: 1040-1045.
18. ABU-SHAKRA, M., D. GLADMAN & M.B. UROWITZ. 1995. Anticardiolipin antibodies in systemic lupus erythematosus: clinical and laboratory correlations. Am. J. Med. 99: 624-628.
19. CERVERA, R., J.-C. PIETTE, J. FONT, et al. 2002. Euro-Phospholipid Project Group: antiphospholipid syndrome: clinical and immunological manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum. 46: 1019-1027.
20. DREW, P., R.A. ASHERSON, R.J. ZUK, et al. 1987. Aortic occlusion in systemic lupus erythematosus associated with antiphospholipid antibodies. Ann. Rheum. Dis. 46: 612-616.
21. TER BORG, E.J., J. VAN DER MEER, J.T.M. DE WOLF, et al. 1988. Arterial thrombotic manifestations in young women associated with the lupus anticoagulant. Clin. Rheumatol. 7: 74-7922.
22. HOHLFELD, J., M. SCHNEIDER, R. HEIN, et al. 1996. Thrombosis of the terminal aorta, deep vein thrombosis, recurrent fetal loss, and antiphospholipid antibodies. Vasa 25: 194-199.
23. SEROGUCHI, M.D., Y. FUJISHIMA, I. ABE, et al. 1997. Aortoiliac occlusion associated with the lupus anticoagulant. Report of two cases. Angiology 48: 359-364.
24. MCGEE, G.S., W.H. PEARCE, L. SHARMA, et al. 1992. Antiphospholipid antibodies and arterial thrombosis. Case reports and a review of the literature. Arch. Surg. 127: 342-346.
25. LESSOF, M.H. & L.E. GLYNN. 1959. The pulseless syndrome. Lancet 1: 799-801.
26. FERRANTE, F.M., G.E. MYERSON & J.A. GOLDMAN. 1982. Subclavian artery thrombosis mimicking the aortic arch syndrome in systemic lupus erythematosus. Arthritis Rheum. 25: 1501-1504.
27. ASHERSON, R.A., E.N. HARRIS, A.E. GHARAVI, et al. Aortic arch syndrome associated with anticardiolipin antibodies and the lupus anticoagulant: comment on Ferrante paper. Arthritis Rheum. 594-595.
28. ASHERSON, R.A., S.C. MAYOU, P. MERRY, et al. 1989. The spectrum of livedo reticularis and anticardiolipin antibodies. Br. J. Dermatol. 120: 215-221.
29. ASHERSON, R.A. & M. KHAMASHTA. 1989. Sneddon's syndrome. Neurology 39: 2238-2239.
30. SNEDDON, I.B. 1965. Cerebro-vascular lesions and livedo reticularis. Br. J. Dermatol. 77: 180-185.
31. TOUBIE, E., I. KRAUSE, A. FRASER, et al. 2005. Livedo reticularis as a marker for predicting multi-organ thrombosis in antiphospholipid syndrome. Clin. Exp. Rheumatol. 23: 499-504.
32. KALASHNIKOVA, L.A., E.L. NASONOV, V.V. BORISENKO, et al. 1991. Sneddon's syndrome: cardiac pathology and antiphospholipid antibodies. Clin. Exp. Rheumatol. 9: 357-361.
33. ASHERSON, R.A. 2006. New subsets of the antiphospholipid syndrome in 2006: "PRE-APS"(Probable APS) and microangiopathic antiphospholipid syndromes ("MAPS"). Autoimmun. Rev. 6: 76-80.
34. AMES, P.R., A. MARGARITA, K.B. SOKOLL, et al. 2005. Premature atherosclerosis and primary antiphospholipid syndrome. Preliminary data. Ann. Rheum. Dis. 64: 315-317.
35. KROEGER, K. & E. KREUZFELDER. 20004. Autoantibodies and peripheral arterial occlusive disease. Herz 1: 26-31.
36. KOBAYASHI, K., M. KISHI, T. ATSUMI, et al. 2003. Circulating oxidized LDL forms complexes with beta-2-glycoprotein 1: implication as an atherogenic autoantigen. J. Lipid Res. 44: 716-726.
37. SHERER, Y. & Y. SHOENFELD. 2003. Antiphospholipid antibodies; are they proatherogenic or an epiphenomenona of atherosclerosis? Immunobiology 207: 13-16.
38. MERRILL, J. & R.A. ASHERSON. 2006. Catastrophic antiphospholipid syndrome nature. Clin. Prac. Rhematol. 2: 82-89.
39. ASHERSON, R.A., R. CERVERA, P.G. DE GROOT, et al. 2003. Catastrophic antiphospholipid syndrome; international consensus statement on classification criteria and treatment guidelines. Lupus 12: 530-534.
40. CERVERA, R., J. FONT, J.A. GOMEZ-P UERTA, et al. 2005. Validation of the preliminary criteria for the classification of the catastrophic antiphospholipid syndrome. Ann. Rheum. Dis. 64: 2005-2009.
41. ASHERSON, R.A. & Y. SHOENFELD. 2000. The role of infection in the pathogenesis of the catastrophic antiphospholipid syndrome molecular mimicry? J. Rheumatol. 27: 12-14.
42. CERVERA, R. & R.A. ASHERSON. 2005. Antiphospholipid antibodies associated with infections; clinical and microbiological characteristics. Immunobiology 210: 735-741.
43. GOMEZ- PUERTA, J.A., R. CERVERA, G. ESPINOZA, et al. 2006. Pregnancy and puerperium are high susceptibility periods for the development of catastrophic antiphospholipid syndrome. Autoimmun. Rev. 6: 85-88.
44. MIESBACH, W., R.A. ASHERSON, R. CERVERA, et al. 2006. The catastrophic antiphospholipid (Asherson's) syndrome and malignancies. Autoimmun. Rev. 6: 94-97. [Epub 2006 Jul 21].
45. GOMEZ-PUERTA, R.A., R. CERVERA, G. ESPINOZA, et al. 2006. Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients. Semin. Arthritis Rheum. 35: 322-332.
46. KITCHENS, C.S. 1998. Thrombotic storm: when thrombosis begets thrombosis. Am. J. Med. 104: 381-385.
47. BIRD, A.G., R. LENDRUM, R.A. ASHERSON & G.R.V. HUGHES. 1987. Disseminated intravascular coagulation, antiphospholipid antibodies, and ischemic necrosis of extremities. Ann. Rheum. Dis. 46: 251-255.
48. SLOFSTRA, S.H., A. SPEK & H. TEN CATE. 2003. Disseminated intravascular coagulation. Haematol. J. 4: 295-302.
49. TAYLOR, F.B. JR, C.H. TOH, W.K. HOOTS, et al. 2001. Toward definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb. Hemost. 86: 1327-1330.
50. ASHERSON, R.A., G. ESPINOZA, R. CERVERA, et al. 2005. Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients. Ann. Rheum. Dis. 64: 943-994.